Filament Health revenue slides 94% as cash reserves dwindle
Vancouver-based Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) saw its cash reserves continue to decline as third-quarter revenue plummeted to $19,021, from $337,470 in the same period last year, according to financial results Thursday. The clinical-stage psychedelic drug development firm ended September with $878,717 in cash and cash equivalents, less than half of the […]
